GlassScriptPhysician profile
Victoria Ruch
NPI 1386237303
$353.53
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.65 · 2022: $159 · 2023: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $66.65 | 2022-2023 | Wegovy |
| Lilly USA, LLC | $64.55 | 2022-2023 | Mounjaro |
| Paratek Pharmaceuticals, INC. | $50.00 | 2021 | |
| Eisai INC. | $22.53 | 2021 | |
| Sanofi Pasteur INC. | $21.90 | 2022 | |
| Seqirus USA INC | $21.86 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Astellas Pharma US INC | $18.89 | 2023 | Myrbetriq |
| Pfizer INC. | $17.72 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $16.12 | 2021 | |
| Merck Sharp & Dohme LLC | $14.50 | 2022 | |
| Exact Sciences Corporation | $14.06 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $12.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Ruch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.